EUVIMEDEUVIMED entdecken
Crossref

Association between non-melanoma skin cancer, psoriasis, and immunomodulatory therapy: a national epidemiologic study

Harrison Zhu, Vikram Shaw, Yelena Dokic, Isabella Camacho-Hubbard, Jennifer S Ranario, Ida F Orengo

Archives of Dermatological Research · 2024

DOI: 10.1007/s00403-024-03649-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Dermatological Research, 2024. Verfasst von Harrison Zhu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Baylor College of Medicine, 1 Baylor Plaza, Houston, TX, 77025, USA. Harrison.zhu@bcm.edu. Hauptthemen laut MEDLINE: Psoriasis, Skin Neoplasms. Die Arbeit nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The association between psoriasis and non-melanoma skin cancer (NMSC) remains inconsistent despite biologic plausibility. Immunosuppressive effects of systemic psoriasis treatments have also been hypothesized to contribute to the development of NMSC as well. However, data assessing the risk of NMSC associated with immunomodulatory psoriasis medications, particularly newer biologic therapies, are limited.Our objective was to quantify the association between psoriasis, systemic psoriasis therapy, and NMSC accounting for other relevant factors such as smoking status and ultraviolet (UV) light exposure.We performed a cross-sectional, case-control study of 413,457 adults containing 7,478 psoriasis and 9,756 NMSC cases taken from the National Institutes of Health All of Us Research Program database (queried July 2024). NMSC, psoriasis, UV-light exposure, and drug exposures were defined using disease or drug classification codes. Smoking exposure was defined using survey data. Multivariable logistic regression models were used to assess relationships, providing adjusted odds ratios with 95% confidence intervals (aOR with 95% CI).After adjustment for UV-light exposure, coal tar exposure, smoking status, race, ethnicity, gender, age, income, and insurance status, psoriasis history was a significant predictor for NMSC (aOR 1.37 95% CI 1.22-1.52). Psoriasis patients exposed to immunomodulatory medications were also at higher odds of NMSC compared to psoriasis patients who were never exposed (aOR 1.26 95% CI 1.01-1.57). Of these drugs, IL-23 inhibitors (aOR 2.47 95% CI 1.17-5.18), Janus kinase inhibitors (aOR 2.32 95% CI 1.09-4.92), and azathioprine (aOR 2.16 95% CI 1.18-3.96) were the only classes that significantly contributed to increased NMSC risk in psoriasis patients.Psoriasis is independently associated with NMSC. While treatment with some classes of systemic medications is also associated with increased NMSC risk, therapeutic benefits are significant and should be weighed against this risk. NMSC is treatable and high-risk patients may benefit from increased surveillance or preventative counseling. Further prospective studies that assess medication dose and length of exposure should validate our findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsoriasisSkin NeoplasmsHumansMaleFemaleMiddle AgedCase-Control StudiesAdultCross-Sectional StudiesUnited StatesAgedUltraviolet RaysRisk FactorsSmokingImmunomodulating Agents

Substanzen

Immunomodulating Agents

Autor:innen und Institutionen

  • Baylor College of Medicine, 1 Baylor Plaza, Houston, TX, 77025, USA. Harrison.zhu@bcm.edu.
  • Baylor College of Medicine, 1 Baylor Plaza, Houston, TX, 77025, USA.
  • Department of Dermatology, Baylor College of Medicine, Houston, TX, USA.

Zitieren

APA

Zhu, H., Shaw, V., Dokic, Y., Camacho-Hubbard, I., Ranario, J. S., & Orengo, I. F. (2024). Association between non-melanoma skin cancer, psoriasis, and immunomodulatory therapy: a national epidemiologic study. Archives of Dermatological Research. https://doi.org/10.1007/s00403-024-03649-y

Vancouver

Zhu H, Shaw V, Dokic Y, Camacho-Hubbard I, Ranario JS, Orengo IF. Association between non-melanoma skin cancer, psoriasis, and immunomodulatory therapy: a national epidemiologic study. Archives of Dermatological Research. 2024. doi:10.1007/s00403-024-03649-y

BibTeX
@article{Zhu2024,
  author = {Zhu, Harrison and Shaw, Vikram and Dokic, Yelena and Camacho-Hubbard, Isabella and Ranario, Jennifer S and Orengo, Ida F},
  title = {Association between non-melanoma skin cancer, psoriasis, and immunomodulatory therapy: a national epidemiologic study},
  journal = {Archives of Dermatological Research},
  year = {2024},
  doi = {10.1007/s00403-024-03649-y}
}
Kostenlos starten →